These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

247 related items for PubMed ID: 35064929

  • 1. Muscle Transcriptomics Shows Overexpression of Cadherin 1 in Inclusion Body Myositis.
    Ikenaga C, Date H, Kanagawa M, Mitsui J, Ishiura H, Yoshimura J, Pinal-Fernandez I, Mammen AL, Lloyd TE, Tsuji S, Shimizu J, Toda T, Goto J.
    Ann Neurol; 2022 Mar; 91(3):317-328. PubMed ID: 35064929
    [Abstract] [Full Text] [Related]

  • 2. Ubiquitin immunostaining and inclusion body myositis: study of 30 patients with inclusion body myositis.
    Prayson RA, Cohen ML.
    Hum Pathol; 1997 Aug; 28(8):887-92. PubMed ID: 9269823
    [Abstract] [Full Text] [Related]

  • 3. Expression of matrix metalloproteinases in the muscle of patients with inflammatory myopathies.
    Choi YC, Dalakas MC.
    Neurology; 2000 Jan 11; 54(1):65-71. PubMed ID: 10636127
    [Abstract] [Full Text] [Related]

  • 4. Machine learning algorithms reveal unique gene expression profiles in muscle biopsies from patients with different types of myositis.
    Pinal-Fernandez I, Casal-Dominguez M, Derfoul A, Pak K, Miller FW, Milisenda JC, Grau-Junyent JM, Selva-O'Callaghan A, Carrion-Ribas C, Paik JJ, Albayda J, Christopher-Stine L, Lloyd TE, Corse AM, Mammen AL.
    Ann Rheum Dis; 2020 Sep 11; 79(9):1234-1242. PubMed ID: 32546599
    [Abstract] [Full Text] [Related]

  • 5. Expression of lysosome-related proteins and genes in the skeletal muscles of inclusion body myositis.
    Kumamoto T, Ueyama H, Tsumura H, Toyoshima I, Tsuda T.
    Acta Neuropathol; 2004 Jan 11; 107(1):59-65. PubMed ID: 14513262
    [Abstract] [Full Text] [Related]

  • 6. Comparative utility of LC3, p62 and TDP-43 immunohistochemistry in differentiation of inclusion body myositis from polymyositis and related inflammatory myopathies.
    Hiniker A, Daniels BH, Lee HS, Margeta M.
    Acta Neuropathol Commun; 2013 Jul 01; 1():29. PubMed ID: 24252466
    [Abstract] [Full Text] [Related]

  • 7. Cell type mapping of inflammatory muscle diseases highlights selective myofiber vulnerability in inclusion body myositis.
    Wischnewski S, Thäwel T, Ikenaga C, Kocharyan A, Lerma-Martin C, Zulji A, Rausch HW, Brenner D, Thomas L, Kutza M, Wick B, Trobisch T, Preusse C, Haeussler M, Leipe J, Ludolph A, Rosenbohm A, Hoke A, Platten M, Weishaupt JH, Sommer CJ, Stenzel W, Lloyd TE, Schirmer L.
    Nat Aging; 2024 Jul 01; 4(7):969-983. PubMed ID: 38834884
    [Abstract] [Full Text] [Related]

  • 8. p62/SQSTM1 is overexpressed and prominently accumulated in inclusions of sporadic inclusion-body myositis muscle fibers, and can help differentiating it from polymyositis and dermatomyositis.
    Nogalska A, Terracciano C, D'Agostino C, King Engel W, Askanas V.
    Acta Neuropathol; 2009 Sep 01; 118(3):407-13. PubMed ID: 19557423
    [Abstract] [Full Text] [Related]

  • 9. TWEAK in inclusion-body myositis muscle: possible pathogenic role of a cytokine inhibiting myogenesis.
    Morosetti R, Gliubizzi C, Sancricca C, Broccolini A, Gidaro T, Lucchini M, Mirabella M.
    Am J Pathol; 2012 Apr 01; 180(4):1603-13. PubMed ID: 22314077
    [Abstract] [Full Text] [Related]

  • 10. Mitochondrial DNA variants in inclusion body myositis characterized by deep sequencing.
    Hedberg-Oldfors C, Lindgren U, Basu S, Visuttijai K, Lindberg C, Falkenberg M, Larsson Lekholm E, Oldfors A.
    Brain Pathol; 2021 May 01; 31(3):e12931. PubMed ID: 33354847
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Bcl-2, Bcl-x, and Bax expression by immunohistochemistry in inclusion body myositis: a study of 27 cases.
    Prayson RA, Yu AC.
    Arch Pathol Lab Med; 2001 Oct 01; 125(10):1326-30. PubMed ID: 11570908
    [Abstract] [Full Text] [Related]

  • 15. Morphologic and Molecular Patterns of Polymyositis With Mitochondrial Pathology and Inclusion Body Myositis.
    Kleefeld F, Uruha A, Schänzer A, Nishimura A, Roos A, Schneider U, Goebel HH, Schuelke M, Hahn K, Preusse C, Stenzel W.
    Neurology; 2022 Nov 15; 99(20):e2212-e2222. PubMed ID: 36195449
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Inclusion body myositis.
    Dimachkie MM, Barohn RJ.
    Neurol Clin; 2014 Aug 15; 32(3):629-46, vii. PubMed ID: 25037082
    [Abstract] [Full Text] [Related]

  • 18. Unravelling inclusion body myositis using a patient-derived fibroblast model.
    Cantó-Santos J, Valls-Roca L, Tobías E, García-García FJ, Guitart-Mampel M, Esteve-Codina A, Martín-Mur B, Casado M, Artuch R, Solsona-Vilarrasa E, Fernandez-Checa JC, García-Ruiz C, Rentero C, Enrich C, Moreno-Lozano PJ, Milisenda JC, Cardellach F, Grau-Junyent JM, Garrabou G.
    J Cachexia Sarcopenia Muscle; 2023 Apr 15; 14(2):964-977. PubMed ID: 36860172
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Senescent fibro-adipogenic progenitors are potential drivers of pathology in inclusion body myositis.
    Nelke C, Schroeter CB, Theissen L, Preusse C, Pawlitzki M, Räuber S, Dobelmann V, Cengiz D, Kleefeld F, Roos A, Schoser B, Brunn A, Neuen-Jacob E, Zschüntzsch J, Meuth SG, Stenzel W, Ruck T.
    Acta Neuropathol; 2023 Nov 15; 146(5):725-745. PubMed ID: 37773216
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.